Pouplier, Anna
Fridh, Martin Kaj
Schmidt-Andersen, Peter
Nielsen, Anne Meilandt Langdal
Winther, Helle
Christensen, Jan
Larsen, Hanne Bækgaard
Funding for this research was provided by:
Kræftens Bekæmpelse (R-284-A16272-20-S15; R296-A16956; R327-A18909; R335-A19468, R-284-A16272-20-S15; R296-A16956; R327-A18909; R335-A19468, R-284-A16272-20-S15; R296-A16956; R327-A18909; R335-A19468, R-284-A16272-20-S15; R296-A16956; R327-A18909; R335-A19468, R-284-A16272-20-S15; R296-A16956; R327-A18909; R335-A19468)
Børnecancerfonden (2019-5947; 2020-6756; 2021-7400; 2022-8129, 2019-5947; 2020-6756; 2021-7400; 2022-8129, 2019-5947; 2020-6756; 2021-7400; 2022-8129)
Engineer Captain Aage Nielsen's Family Foundation
National Hospital
Article History
Received: 12 June 2025
Revised: 15 July 2025
Accepted: 21 July 2025
First Online: 6 August 2025
Change Date: 14 August 2025
Change Type: Update
Change Details: The original online version of this article was revised to correct the author in the last authorship note.
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki II. The Regional Research Ethics Committee in the Capital Region of Denmark approved the RePlay trial (jr.nr.: H-20023949), and the Danish Data Protection Agency approved the handling of data (jr. nr.: P-2020–290).
: Informed parental consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.